Smoking cessation is related to change in metabolic syndrome onset: A rural cohort study

Abstract

INTRODUCTION Relatively few, mainly cross-sectional, studies have examined the relationship between smoking cessation and metabolic syndrome (MetS). In particular, information on smoking cessation after MetS is limited. This study aimed to investigate the probability of smoking cessation after the onset of MetS. METHODS In this study we used cohort data from a rural area of Korea and extracted the data of 1054 smokers who were identifiable at baseline and were followed up. Of these, 1041 individuals were selected. Descriptive statistical analyses were performed to identify the basic characteristics of smokers. Multiple logistic regression was performed to determine the association between changes in MetS and smoking cessation. RESULTS The probability of smoking cessation was 1.84 times higher in the newly developed MetS cohort than in the reference group (without MetS at any time point), and it was 1.61 times higher in the persistent MetS cohort than in the reference group, with both probabilities being significant. CONCLUSIONS We found that patients with MetS were more likely to quit smoking than those without MetS. However, intervention is still needed, as numerous patients with MetS continued to smoke. Interventions that actively involve medical institutions or organizations are among the most effective approaches to promote smoking cessation in patients with MetS. In particular, women, farmers and current drinkers should be prioritized.

Smoking cessation and risk of metabolic syndrome: A meta-analysis

“…The characteristics of the eligible studies are summarized in Table 1. Of the 24 articles included in the study, 13 were cross-sectional studies, [10,17–22,25,27–29,31,36] 10 were cohort studies, [3,19,23,24,26,32,33,35,37,38] 1 was a randomized controlled trial (RCT), [30] and 1 was a case-control study. [34] Regarding region, 15 studies in Asia, 4 in Europe, 3 in Middle East, and 2 in America were conducted.…”

“…This resulted in significant heterogeneity among studies. Third, some studies did not consider factors such as weight change [24,33,38] or the amount of smoking [20] before cessation, which has had an impact on the analysis Furthermore, only 41% of the studies have reported the duration of smoking cessation, [3,10,[19][20][21]23,24,26,30,32,35,38] and the varying timeframes across different studies make it challenging to integrate the findings. Of the 5 studies involving women, [17,18,22,23,34] available data on the prevalence of MS based on smoking status are scarce, thus making it difficult to include it in the analysis.…”

“…The characteristics of the eligible studies are summarized in Table 1. Of the 24 articles included in the study, 13 were cross-sectional studies, [10,[17][18][19][20][21][22]25,[27][28][29]31,36] 10 were cohort studies, [3,19,23,24,26,32,33,35,37,38] 1 was a randomized controlled trial (RCT), [30] and 1 was a case-control study. [34] Regarding region, 15 Kim et al [33] South Korea Prospective cohort study Oh et al [34] South Korea Case-control study Park et al [37] South Korea Cohort study Population based All 6,099,717…”